Skip to content Skip to sidebar Skip to footer

At the end of today’s trading session on the Nairobi Securities Exchange (NSE).

A  total of 63,060,600 shares in 1,536 deals, corresponding to a market value of KES 1,848,500,206.00, were traded.

Compared to the previous NSE trading day (Wednesday, March 11), today’s data shows 281% improvement in volume, 315% improvement in turnover, and 87% improvement in deals.

The current NSE market capitalization is KES 2.15 trillion.

In the aggregate, 45 NSE listed equities participated in trading, ending with 7 gainers and 31 losers.

Standard Group Plc [SGL] led the gainers with ✅7.14% share price appreciation closing at KES 22.50 per share, followed by:

✅Unga Group Plc [UNGA] (+6.33%)
✅STANLIB Fahari Income REIT [FAHR] (+4.74%)
✅Liberty Kenya Holdings Plc [LBTY] (+2.03%).

On the losing side, Nairobi Business Ventures [NBV] came out last with an end-of-day price depreciation of ?9.09% closing at KES 0.60 per share, followed by:

?Sanlam Kenya Plc [SLAM] (-8.82%)
?Kenya Re-Insurance Corporation [KNRE] (-8.46%)
?Safaricom Plc [SCOM] (-7.54%).

Safaricom Plc [SCOM] recorded the highest volume of 38.1 million traded shares, followed by:

➖Equity Group Holdings Plc [EQTY] (7.39m)
➖KCB Group Plc [KCB] (7.09m)
➖Kenya Re-Insurance Corporation [KNRE] (5.01m).

➡️The benchmark NSE All Share Index [NASI] dropped ?7.71 points to close at 141.46

➡️The NSE 20 Share Index dropped ?79.77 points to close at 2236.81

➡️The NSE 25 Share Index dropped ?163.01 points to close at 3548.51

The Derivatives Market had one KCB contract worth Kes.47,000 expiring in 19th March 2020 was concluded at a price of Kes.47.00. This is against an end of day price of Kes.45.85 posted in the spot market.

The secondary Bond market at the NSE continued to record a decline in activity in today’s trading session with bonds worth Kes 2.33 Billion traded in 140 deals on the Fixed income segment as compared to yesterday’s 155 deals valued at Kes 3.08 Billion.

Source: NSE

Reporting by The Trading Room.

1 Comment

Comments are closed.